
RedDress
Advanced biologic wound care solutions revolutionizing chronic wound treatment with natural healing processes.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
* | $26.0m | Series D | |
Total Funding | 000k |
Related Content
RedDress Medical is a healthcare company focused on revolutionizing the treatment of chronic wounds through advanced biologic wound care solutions. Founded in 2009 by Dr. Igal Kushnir MD and Alon Kushnir, the company aims to develop more effective, natural, and economically viable treatments for chronic wounds. RedDress Medical's flagship product, ActiGraft, leverages proprietary, patented technology to recreate the body's natural wound healing processes, offering a cost-effective solution for managing difficult wounds. The company serves a diverse range of clients, including hospitals, clinics, and healthcare providers, primarily in the chronic wound care market. RedDress Medical operates on a B2B (business-to-business) model, generating revenue through the sale of its innovative wound care products to medical institutions. The company's mission is to improve the health and lives of patients worldwide by providing advanced, cost-effective chronic wound treatments that benefit both patients and medical professionals.
Keywords: chronic wounds, biologic solutions, wound care, ActiGraft, healthcare, natural healing, cost-effective, medical technology, B2B, innovation.